Laertis Ikonomou

Laertis Ikonomou

Auto-generated profile, based on publicly available information

Laertis Ikonomou

Department of Oral Biology, University at Buffalo School of Dental Medicine, Buffalo, NY 14215, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2010 in Nature Medicine
Verified
Journal Article
Closed access
HOHarald C Ott
Harald C Ott
BCBen Clippinger
Ben Clippinger
CCClaudius Conrad
Claudius Conrad
CSChristian Schuetz
Christian Schuetz
IPIrina Pomerantseva
Irina Pomerantseva
JVJoseph P Vacanti
Joseph P Vacanti

1 April 2012 in Cell Stem Cell
Verified
Journal Article
Closed access
TLTyler A. Longmire
Tyler A. Longmire
LILaertis Ikonomou
Laertis Ikonomou
FHFinn Hawkins
Finn Hawkins
CCConstantina Christodoulou
Constantina Christodoulou
YCYuxia Cao
Yuxia Cao
DKDarrell N. Kotton
Darrell N. Kotton

6 May 2003 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
LIL. Ikonomou
L. Ikonomou
YSY.-J. Schneider
Y.-J. Schneider
Spiros N. AgathosSpiros N. Agathos
Spiros N. Agathos

1 February 2012 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
PDPatricia I. Diaz
Patricia I. Diaz
ZXZhihong Xie
Zhihong Xie
TSTakanori Sobue
Takanori Sobue
ATAngela Thompson
Angela Thompson
BBBasak Biyikoglu
Basak Biyikoglu
ADAnna Dongari-Bagtzoglou
Anna Dongari-Bagtzoglou
Candida albicans is a commensal colonizer of the gastrointestinal tract of humans, where it coexists with highly diverse bacterial communities. It is not clear whether this interaction limits or promotes the potential of C. albicans to become an opportunistic pathogen. Here we investigate the interaction between C. albicans and three species of streptococci from the viridans group, which are ubiquitous and abundant oral commensal bacteria. The ability of C. albicans to form biofilms with Streptococcus oralis , Streptococcus sanguinis , or Streptococcus gordonii was investigated using flow cell devices that allow abiotic biofilm formation under salivary flow. In addition, we designed a novel flow cell system that allows mucosal biofilm formation under conditions that mimic the environment in the oral and esophageal mucosae. It was observed that C. albicans and streptococci formed a synergistic partnership where C. albicans promoted the ability of streptococci to form biofilms on abiotic surfaces or on the surface of an oral mucosa analogue. The increased ability of streptococci to form biofilms in the presence of C. albicans could not be explained by a growth-stimulatory effect since the streptococci were unaffected in their growth in planktonic coculture with C. albicans . Conversely, the presence of streptococci increased the ability of C. albicans to invade organotypic models of the oral and esophageal mucosae under conditions of salivary flow. Moreover, characterization of mucosal invasion by the biofilm microorganisms suggested that the esophageal mucosa is more permissive to invasion than the oral mucosa. In summary, C. albicans and commensal oral streptococci display a synergistic interaction with implications for the pathogenic potential of C. albicans in the upper gastrointestinal tract.

1 November 2015 in Cell Stem Cell
Verified
Journal Article
Closed access
AKAnita A. Kurmann
Anita A. Kurmann
MSMaria Serra
Maria Serra
FHFinn Hawkins
Finn Hawkins
SRScott A. Rankin
Scott A. Rankin
MMMunemasa Mori
Munemasa Mori
DKDarrell N. Kotton
Darrell N. Kotton

27 September 2007 in Stem Cells
Verified
Journal Article
Closed access
PDF file
BDBehrous Davani
Behrous Davani
LILaertis Ikonomou
Laertis Ikonomou
BRBruce M. Raaka
Bruce M. Raaka
EGElizabeth Geras-Raaka
Elizabeth Geras-Raaka
RMRussell A. Morton
Russell A. Morton
MGMarvin Gershengorn
Marvin Gershengorn
Islet transplantation offers improved glucose homeostasis in diabetic patients, but transplantation of islets is limited by the supply of donor pancreases. Undifferentiated precursors hold promise for cell therapy because they can expand before differentiation to produce a large supply of functional insulin-producing cells. Previously, we described proliferative populations of human islet-derived precursor cells (hIPCs) from adult islets. To show the differentiation potential of hIPCs, which do not express insulin mRNA after at least 1,000-fold expansion, we generated epithelial cell clusters (ECCs) during 4 days of differentiation in vitro. After transplantation into mice, 22 of 35 ECC preparations differentiated and matured into functional cells that secreted human C-peptide in response to glucose. Transcripts for insulin, glucagon, and somatostatin in recovered ECC grafts increased with time in vivo, reaching levels approximately 1% of those in adult islets. We show that hIPCs are mesenchymal stromal cells (MSCs) that adhere to plastic, express CD73, CD90, and CD105, and can differentiate in vitro into adipocytes, chondrocytes, and osteocytes. Moreover, we find a minor population of CD105+/CD73+/CD90+ cells in adult human islets (prior to incubation in vitro) that express insulin mRNA at low levels. We conclude that hIPCs are a specific type of pancreas-derived MSC that are capable of differentiating into hormone-expressing cells. Their ability to mature into functional insulin-secreting cells in vivo identifies them as an important adult precursor or stem cell population that could offer a virtually unlimited supply of human islet-like cells for replacement therapy in type 1 diabetes. Disclosure of potential conflicts of interest is found at the end of this article.